Cortisol levels and risk for psychosis: Initial findings from the North American Prodrome Longitudinal Study

Biological Psychiatry

Volumn 74, Issue 6, 2013, Pages 410-417

  Walker, Elaine F ^a   Trotman, Hanan D ^a   Pearce, Brad D ^a   Addington, Jean ^b   Cadenhead, Kristin S ^c   Cornblatt, Barbara A ^d   Heinssen, Robert ^e   Mathalon, Daniel H ^f   Perkins, Diana O ^g   Seidman, Larry J ^h   Tsuang, Ming T ^h,i   Cannon, Tyrone D ^j   McGlashan, Thomas H ^k   Woods, Scott W ^k  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j YALE UNIVERSITY   (United States)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Cortisol; high risk; longitudinal; prodrome; psychosis; stress

Indexed keywords

HYDROCORTISONE;

ADOLESCENCE; ADULT; AGE; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SALIVA ANALYSIS; SCHOOL CHILD;

EID: 84882689866     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.02.016     Document Type: Article

References (57)

1. E. Walker, V. Mittal, and K. Tessner Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia Annu Rev Clin Psychol 4 2008 189 216
2. C.W. Holtzman, H.D. Trotman, S.M. Goulding, A.T. Ryan, A.N. McDonald, and D.I. Shapiro Stress and neurodevelopmental processes in the emergence of psychosis [published online ahead of print January 5] Neuroscience. 2013 10.1016/j.neuroscience.2012.12.017
3. V. Mondelli, P. Dazzan, N. Hepgul, M. Di Forti, M. Aas, and A. D'Albenzio Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment Schizophr Res 116 2010 234 242
4. P.C. Guest, E. Schwarz, D. Krishnamurthy, L.W. Harris, F.M. Leweke, and M. Rothermundt Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia Psychoneuroendocrinology 36 2011 1092 1096
5. N.E. Steen, M. Tesli, A.K. Kahler, P. Methlie, S. Hope, and E.A. Barrett SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders Prog Neuropsychopharmacol Biol Psychiatry 34 2010 1500 1506
6. C. Stetler, and G.E. Miller Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research Psychosom Med 73 2011 114 126
7. O. Yildirim, O. Dogan, M. Semiz, and F. Kilicli Serum cortisol and dehydroepiandrosterone-sulfate levels in schizophrenic patients and their first-degree relatives Psychiatry Clin Neurosci 65 2011 584 591
8. D. Collip, N.A. Nicolson, M. Lardinois, T. Lataster, J. Van Os, and I. Myin-Germeys Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis Psychol Med 41 2011 2305 2315
9. B. Garner, C. Phassouliotis, L.J. Phillips, C. Markulev, F. Butselaar, and S. Bendall Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis J Psychiatr Res 45 2011 249 255
10. M. Belvederi Murri, C.M. Pariante, P. Dazzan, N. Hepgul, A.S. Papadopoulos, and P. Zunszain Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis Psychoneuroendocrinology 37 2012 629 644
11. T.J. Miller, T.M. McGlashan, J.L. Rosen, K. Cadenhead, J. Ventura, and W. McFarlane Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive validity, inter-rater reliability, and training to reliability Schizophr Bull 29 2003 703 715
12. K.A. Olsen, and B. Rosenbaum Prospective investigations of the prodromal state of schizophrenia: Assessment instruments Acta Psychiat Scand 113 2006 273 282
13. T.D. Cannon, K. Cadenhead, B. Cornblatt, S.W. Woods, J. Addington, and E. Walker Prediction of psychosis in youth at clinical high risk: A multisite longitudinal study in North America Arch Gen Psychiatry 65 2008 28 37
14. S. Ruhrmann, F. Schultze-Lutter, R.K.R. Salokangas, M. Heinimaa, D. Linszen, and P. Dingemans Prediction of psychosis in adolescents and young adults at high risk: Results from the Prospective European Prediction of Psychosis study Arch Gen Psychiatry 67 2010 241 251
15. D. Gothelf, F. Hoeft, T. Ueno, L. Sugiura, A.D. Lee, P. Thompson, and A.L. Reiss Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome J Psychiatr Res 45 2011 322 331
16. S. Jacobson, I. Kelleher, M. Harley, A. Murtagh, M. Clarke, and M. Blanchard Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren Neuroimage 49 2010 1875 1885
17. W.H. Jung, J.S. Kim, J.H. Jang, J.S. Choi, M.H. Jung, and J.Y. Park Cortical thickness reduction in individuals at ultra-high-risk for psychosis Schizophr Bull 37 2011 839 849
18. H. Witthaus, M. Brune, C. Kaufmann, G. Bohner, S. Ozgurdal, and Y. Gudlowski White matter abnormalities in subjects at ultra-high-risk for schizophrenia and first-episode schizophrenic patients Schizophr Res 102 2008 141 149
19. G. Aiello, M. Horowitz, N. Hepgul, C.M. Pariante, and V. Mondelli Stress abnormalities in individuals at risk for psychosis: A review of studies in subjects with familial risk or with "at risk" mental state Psychoneuroendocrinology 37 2012 1600 1613
20. B. Garner, C.M. Pariante, S.J. Wood, D. Velakoulis, L. Phillips, and B. Soulsby Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis Biol Psychiatry 58 2005 417 423
21. K.N. Thompson, L.J. Phillips, H.P. Komesoroff, S. Yuen, H.P. Yuen, and S.J. Wood Stress and HPA-axis functioning in young people at ultra high risk for psychosis J Psychiatr Res 41 2007 561 569
22. K.N. Thompson, G. Berger, L.J. Phillips, P. Komesaroff, R. Purcell, and P.D. McGorry HPA axis functioning associated with transition to psychosis: Combined DEX/CRH test J Psychiatr Res 41 2007 446 450
23. D.D. Weinstein, D. Donald, J. Schiffman, E. Walker, and R. Bonsall Minor physical anomalies, dermatoglyphic abnormalities and cortisol secretion in adolescents with schizotypal personality disorder Am J Psychiatry 156 1999 617 623
24. E.F. Walker, P.A. Brennan, M. Esterberg, J. Brasfield, B. Pearce, and M.T. Compton Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth J Abnorm Psychol 119 2010 401 408
25. R. Mizrahi, J. Addington, P.M. Rusjan, I. Suridjan, A. Ng, and I. Boileau Increased stress-induced dopamine release in psychosis Biol Psychiatry 71 2012 561 567
26. V. Mondelli, A. Cattaneo, M.M. Belvederi, M. Di Forti, R. Handley, and N. Hepgul Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume J Clin Psychiatry 72 2011 1677 1684
27. J. Addington, K.S. Cadenhead, B.A. Cornblatt, D.H. Mathalon, T.H. McGlashan, and D.O. Perkins North American Prodrome Longitudinal Study (NAPLS 2): Overview and Recruitment Schizophr Res 142 2012 77 82
28. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) 2002 Biometrics Research, New York State Psychiatric Institute New York
29. I. Li, H.H. Chiou, and P.S. Shen Correlations between cortisol level and internalizing disposition of young children are increased by selecting optimal sampling times and aggregating data Dev Psychobiol 49 2007 633 639
30. J.W. Graham Missing data analysis: Making it work in the real world Annu Rev Psychol 60 2009 549 576
31. S. Van Buuren Multiple imputation of discrete and continuous data by fully conditional specification Stat Methods Med Res 16 2007 219 242
32. R.G. Gomez, J.A. Posener, J. Keller, C. DeBattista, B. Solvason, and A.F. Schatzberg Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function Psychoneuroendocrinology 34 2009 1012 1018
33. K. Van Craenenbroeck, K. De Bosscher, W. Vanden Berghe, P. Vanhoenacker, and G. Haegeman Role of glucocorticoids in dopamine-related neuropsychiatric disorders Mol Cell Endocrinol 245 2005 10 22
34. A.F. Schatzberg, A.J. Rothschild, P.J. Langlais, E.D. Bird, and J.O. Cole A corticosteroid/dopamine hypothesis for psychotic depression and related states J Psychiatr Res 19 1985 57 64
35. J. Keller, B. Flores, R.G. Gomez, H.B. Solvason, H. Kenna, G.H. Williams, and A.F. Schatzberg Cortisol circadian rhythm alterations in psychotic major depression Biol Psychiatry 60 2006 275 281
36. H. Tsukada, H. Ohba, S. Nishiyama, and T. Kakiuchi Differential effects of stress on [11C]raclopride and [11C]MNPA binding to striatal D2/D3 dopamine receptors: A PET study in conscious monkeys Synapse 65 2011 84 89
37. J.C. Pruessner, K. Dedovic, M. Pruessner, C. Lord, C. Buss, and L. Collins Stress regulation in the central nervous system: Evidence from structural and functional neuroimaging studies in human populations Psychoneuroendocrinology 35 2010 179 191
38. G.S. Wand, L.M. Oswald, M.E. McCaul, D.F. Wong, E. Johnson, and Y. Zhou Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress Neuropsychopharmacology 32 2007 2310 2320
39. J.L. Mayer, L. Klumpers, S. Maslam, E.R. De Kloet, M. Joels, and P.J. Lucassen Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis J Neuroendocrinol 18 2006 629 631
40. R.C. Melcangi, G. Panzica, and L.M. Garcia-Segura Neuroactive steroids: Focus on human brain Neuroscience 191 2011 1 5
41. P. Vigil, R.F. Orellana, M.E. Cortés, and C.T. Molina Endocrine modulation of the adolescent brain: A review J Pediatr Adolesc Gynecol 24 2011 330 337
42. J.S. Peper, H.E. Hulshoff Pol, E.A. Crone, and J. van Honk Sex steroids and brain structure in pubertal boys and girls: A mini-review of neuroimaging studies Neuroscience 191 2011 28 37
43. M.M. Herting, E.C. Maxwell, and C. Irvine The impact of sex, puberty, and hormones on white matter microstructure in adolescents Cereb Cortex 22 2012 1979 1992
44. V. Mondelli, C.M. Pariante, S. Navari, M. Aas, A. D'Albenzio, and M. Di Forti Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis Schizophr Res 119 2010 75 78
45. K.D. Tessner, E.F. Walker, S.H. Dhruv, K. Hochman, and S. Hamann The relation of cortisol levels with hippocampus volumes under baseline and challenge conditions Brain Res 1179 2007 70 78
46. J. Castro-Fornieles, N. Bargallo, L. Lazaro, S. Andres, C. Falcon, M.T. Plana, and C. Junque A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa J Psychiatr Res 43 2009 331 340
47. A.O. Bennett Stress and anxiety in schizophrenia and depression: Glucocorticoids, corticotropin-releasing hormone and synapse regression Aust N Z J Psychiatry 42 2008 995 1002
48. M.R. Asato, R. Terwilliger, J. Woo, and B. Luna White matter development in adolescence: A DTI study Cereb Cortex 20 2010 2122 2131
49. G. Issa, C. Wilson, A.V. Terry Jr, and A. Pillai An inverse relationship between cortisol and BDNF levels in schizophrenia: Data from human postmortem and animal studies Neurobiol Dis 38 2010 327 333
50. C. Miodownik, R. Maayan, Y. Ratner, V. Lerner, L. Pintov, and M. Mar Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients Clin Neuropharmacol 34 2011 155 160
51. M.S. Lee, H.S. Choi, S.H. Kwon, K. Morita, and S. Her Identification of the functional domain of glutocorticoid receptor involved in RU486 antagonism J Steroid Biochem Mol Biol 117 2009 67 73
52. D. Sinclair, M.J. Webster, J. Wong, and C.S. Weickert Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development Mol Psychiatry 16 2011 504 515
53. M.P. Howell, and L.J. Muglia Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice Front Neuroendocrinol 27 2006 275 284
54. W.R. Perlman, M.J. Webster, J.E. Kleinman, and C.S. Weickert Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness Biol Psychiatry 56 2004 844 852
55. M.J. Webster, M.B. Knable, J. O'Grady, J. Orthmann, and C.S. Weickert Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders Mol Psychiatry 7 2002 985 994 924
56. G.Q. Xing, S. Russell, M.J. Webster, and R.M. Post Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder Int J Neuropsychopharmacol 7 2004 143 153
57. M. Bicikova, R. Hampl, M. Hill, D. Ripova, P. Mohr, and Z. Putz Neuro- and immunomodulatory steroids and other biochemical markers in drug-naïve schizophrenia patients and the effect of treatment with atypical antipsychotics Neuro Endocrinol Lett 32 2011 141 147